MUSCARINIC RECEPTOR MODULATION OF ACETYLCHOLINE-RELEASE FROM RAT CEREBRAL-CORTEX AND HIPPOCAMPUS

被引:46
作者
VANNUCCHI, MG [1 ]
PEPEU, G [1 ]
机构
[1] UNIV FLORENCE, DEPT PRECLIN & CLIN PHARMACOL, I-50134 FLORENCE, ITALY
关键词
ACETYLCHOLINE RELEASE; MUSCARINIC RECEPTORS; MUSCARINIC ANTAGONISTS;
D O I
10.1016/0304-3940(95)11498-L
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
An attempt to identify the muscarinic receptor subtypes involved in presynaptic modulation of acetylcholine (ACh) release from cortical and hippocampal slices was made by means of several muscarinic antagonists. Cortical and hippocampal slices prepared from adult rats were superfused with Krebs solution containing physostigmine; ACh content of the superfusate at rest and after electrical stimulation (I Hz) was quantified by high performance liquid chromatography. The antagonists were added to the Krebs at the concentration of 1 mu M. ACh release at rest was enhanced only in the cortex by (+/-)-5,11-dihydro-11-{[(2-[2-[(dipropylamino)methyl]-1-piperidinyl}ethyl)amino]carbonyl}-6H-pyrido[2,3-b](1,4)-benzodiazepine-6-one (AFDX384), an M2/M4 selective antagonist. The evoked ACh release from the cerebral cortex was significantly increased by AFDX384, methoctramine, pirenzepine, M2/M4, M2 and M1 selective antagonists, respectively, and scopolamine. This finding suggests that M1, M2 and M4 presynaptic receptor subtypes could regulate evoked ACh release in the cortex. In hippocampal slices, the evoked ACh release was enhanced by AFDX384, pirenzepine and scopolamine but not by methoctramine. In this region ACh release seems therefore regulated only by M1 and M4 receptor subtypes. The M3 antagonist (+/-)-p-fluorohexahydro-sila-difenidol hydrochloride did not affect ACh release.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 26 条
[1]   SECRETION OF ACETYLCHOLINE-H-3 FROM GUINEA-PIG ILEUM MYENTERIC PLEXUS IS ENHANCED BY 8-BR ADENOSINE 3',5'-CYCLIC-MONOPHOSPHATE BUT NOT CHANGED BY 8-BR GUANOSINE 3',5'-CYCLIC-MONOPHOSPHATE [J].
ALBERTS, P ;
STJARNE, L .
ACTA PHYSIOLOGICA SCANDINAVICA, 1982, 115 (02) :269-272
[2]  
ARAUJO DM, 1990, J NEUROSCI, V10, P3069
[3]  
BREHM G, 1992, N-S ARCH PHARMACOL, V346, P375
[4]  
BUCKLEY NJ, 1988, J NEUROSCI, V8, P4646
[5]   DETERMINATION OF ACETYLCHOLINE AND CHOLINE IN THE FEMTOMOLE RANGE BY MEANS OF HPLC, A POST-COLUMN ENZYME REACTOR, AND ELECTROCHEMICAL DETECTION [J].
DAMSMA, G ;
VANBUEREN, DL ;
WESTERINK, BHC ;
HORN, AS .
CHROMATOGRAPHIA, 1987, 24 :827-831
[6]  
DOLEZAL V, 1990, J PHARMACOL EXP THER, V252, P739
[7]  
DORJE F, 1991, J PHARMACOL EXP THER, V256, P727
[8]   THE AUTOINHIBITORY FEEDBACK-CONTROL OF ACETYLCHOLINE-RELEASE IN HUMAN NEOCORTEX TISSUE [J].
FEUERSTEIN, TJ ;
LEHMANN, J ;
SAUERMANN, W ;
VANVELTHOVEN, V ;
JACKISCH, R .
BRAIN RESEARCH, 1992, 572 (1-2) :64-71
[9]   A NOVEL M2-SELECTIVE MUSCARINIC ANTAGONIST - BINDING CHARACTERISTICS AND AUTORADIOGRAPHIC DISTRIBUTION IN RAT-BRAIN [J].
GITLER, MS ;
REBA, RC ;
COHEN, VI ;
RZESZOTARSKI, WJ ;
BAUMGOLD, J .
BRAIN RESEARCH, 1992, 582 (02) :253-260
[10]   PIRENZEPINE DISTINGUISHES BETWEEN DIFFERENT SUBCLASSES OF MUSCARINIC RECEPTORS [J].
HAMMER, R ;
BERRIE, CP ;
BIRDSALL, NJM ;
BURGEN, ASV ;
HULME, EC .
NATURE, 1980, 283 (5742) :90-92